Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Novartis to Pay $422.5M to Settle Off-label Drug Marketing Charges

Novartis Pharmaceuticals Corp. will plead guilty and pay criminal and civil fines totaling $422.5 million to resolve claims that it used off-label marketing to illegally promote the antiepileptic Trileptal and five other drugs, federal prosecutors said Thursday.

Please enter your comment below:
Please enter the text below: